trending Market Intelligence /marketintelligence/en/news-insights/trending/hzIhGeqRQszVmKjunNmt8g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Origin House receives shareholder approval for sale to Cresco Labs

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Origin House receives shareholder approval for sale to Cresco Labs

Origin House has received shareholder approval for the sale of the company to Cresco Labs Inc. for an expected C$1.1 billion.

Ottawa, Ontario-based Origin House said 99.6% of its shareholders voted in favor of the sale.

The company expects to proceed with the receipt of a final court order on Jan. 6, Origin House Chairman and CEO Marc Lustig said, adding that the company expects to close the sale soon after.

The deal, which Chicago-based Cresco previously called the largest acquisition of a public company in the U.S. cannabis sector, was amended in November 2019 to reduce the ratio of Cresco shares awarded in exchange for a share in Origin House from 0.8428 to 0.7031 per common share and 84.28 to 70.31 per class A share.

Origin House is a cannabis brand and distribution company. Cresco Labs manufactures medical cannabis products in the U.S.